Home>
US Stocks>
Crispr Therapeutics Ag

Crispr Therapeutics Ag share price today

(CRSP)

Crispr Therapeutics Ag share price is $55.15 & ₹4,670.38

$55.15

▲

3.98

(7.78%)

Market is closed - opens 8 PM, 03 Dec 2024

View live Crispr Therapeutics Ag share price in Dollar and Rupees. Guide to invest in Crispr Therapeutics Ag from India. Also see the sentimental analysis on Indian investors investing in Crispr Therapeutics Ag. Get details on the Indian mutual funds that are investing in Crispr Therapeutics Ag. Get Analyst recommendations and forecasts along with all the Crispr Therapeutics Ag's financials.

Crispr Therapeutics Ag share price movements

$51.24
$55.42
$55.15
7.09%
Downside
Day's Volatility :7.54%
Upside
0.49%
$43.42
$91.10
$55.15
21.27%
Downside
52 Weeks Volatility :52.34%
Upside
39.46%

Crispr Therapeutics Ag Returns

Period	Crispr Therapeutics Ag	Sector (Health Care)	Index (Russel 2000)
3 Months	21.16%	-6.2%	0.0%
6 Months	-5.36%	1.7%	0.0%
1 Year	-22.88%	11.6%	0.0%
3 Years	-22.46%	12.9%	-18.1%

Crispr Therapeutics Ag Key Statistics

in dollars & INR

Market Capitalization	$4.4B
Revenue TTM	$202.8M
EBITDA	$-313.1M
Earnings Per Share (EPS)	$-2.79
Profit Margin	-118.13%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-13.07%

How to invest in Crispr Therapeutics Ag from India?

It is very easy for Indian residents to invest directly in Crispr Therapeutics Ag from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Crispr Therapeutics Ag stock in both rupees (INR) and dollars (USD). Search for Crispr Therapeutics Ag or CRSP on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Crispr Therapeutics Ag or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Crispr Therapeutics Ag shares which would translate to 0.015 fractional shares of Crispr Therapeutics Ag as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Crispr Therapeutics Ag

9.2%

Period: Sep 3, 2024 to Dec 2, 2024. Change in 30 Days versus previous period

Investment in Crispr Therapeutics Ag from India has grown in the last 30 days as on Dec 3, 2024. 9.2% more purchase transactions for Crispr Therapeutics Ag in the last 30 days versus the previous period.

97%

Period: Sep 3, 2024 to Dec 2, 2024. Change in 30 Days versus previous period

Search volume for Crispr Therapeutics Ag on INDmoney from India has grown in the last 30 days as on Dec 3, 2024. 97% more investors are searching Crispr Therapeutics Ag in the last 30 days versus the previous period.

Global Institutional Holdings in Crispr Therapeutics Ag

Capital Research & Mgmt Co - Division 3
9.29%
ARK Investment Management LLC
8.79%
Nikko Asset Management Americas Inc
3.69%
State Street Corp
3.51%
Sumitomo Mitsui Trust Group Inc
3.48%
BlackRock Inc
3.25%

Analyst Recommendation on Crispr Therapeutics Ag

Buy

54%Buy

37%Hold

8%Sell

Based on 35 Wall street analysts offering stock ratings for Crispr Therapeutics Ag(by analysts ranked 0 to 5 stars)

Based on 35 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Crispr Therapeutics Ag

What analysts predicted

Upside of 48.23%

Current:

$55.15

Target:

$81.75

Insights on Crispr Therapeutics Ag

Increasing Revenue
Revenue is up for the last 3 quarters, 504.0K → 602.0K (in $), with an average increase of 8.3% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -126.40M → -85.94M (in $), with an average increase of 47.1% per quarter
Vs ALNY
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 47.6% return, outperforming this stock by 67.3%
Vs VRTX
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.6% return, outperforming this stock by 68.9%

Crispr Therapeutics Ag Technicals Summary

Sell

Neutral

Buy

Crispr Therapeutics Ag is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Crispr Therapeutics Ag Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Crispr Therapeutics Ag	9.01%	-5.36%	-22.88%	-22.46%	-22.01%
Regeneron Pharmaceuticals, Inc.	-8.02%	-23.25%	-7.41%	21.97%	106.97%
Biontech Se	7.55%	17.81%	17.31%	-58.12%	421.12%
Alnylam Pharmaceuticals, Inc.	-6.28%	68.94%	46.36%	42.94%	103.66%
Vertex Pharmaceuticals Incorporated	-1.5%	-1.94%	32.83%	127.12%	108.78%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Crispr Therapeutics Ag	13.4	NA	-0.21	-5.15	-0.13	-0.1	NA	22.73
Regeneron Pharmaceuticals, Inc.	18.55	18.55	1.12	44.92	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.06	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.23	0.54	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Crispr Therapeutics Ag	Buy	$4.4B	-22.01%	13.4	-118.13%
Regeneron Pharmaceuticals, Inc.	Buy	$83.0B	106.97%	18.55	33.61%
Biontech Se	Buy	$28.9B	421.12%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$32.7B	103.66%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$120.6B	108.78%	32.84	-4.51%

About Crispr Therapeutics Ag

CRISPR Therapeutics is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. CRISPR/Cas9 is a revolutionary gene editing technology that allows for precise, directed changes to genomic DNA. CRISPR Therapeutics has established a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine and rare diseases. To accelerate and expand its efforts, CRISPR Therapeutics has established strategic collaborations with leading companies including Bayer, Vertex Pharmaceuticals and ViaCyte, Inc. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Cambridge, Massachusetts, and business offices in San Francisco, California and London, United Kingdom. For more information, please visit www.crisprtx.com.

Organization	Crispr Therapeutics Ag
Employees	407
CEO	Dr. Samarth Kulkarni Ph.D.
Industry	Health Technology

Important FAQs about investing in Crispr Therapeutics Ag from India :

What is Crispr Therapeutics Ag share price today?

Crispr Therapeutics Ag (CRSP) share price today is $55.15.

Can Indians buy Crispr Therapeutics Ag shares?

Yes, Indians can invest in the Crispr Therapeutics Ag (CRSP) from India.

With INDmoney, you can buy Crispr Therapeutics Ag at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Crispr Therapeutics Ag at zero transaction cost.

How can I buy Crispr Therapeutics Ag shares from India?

It is very easy to buy Crispr Therapeutics Ag from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Crispr Therapeutics Ag be purchased?

Yes, you can buy fractional shares of Crispr Therapeutics Ag with INDmoney app.

What are the documents required to start investing in Crispr Therapeutics Ag stocks?

To start investing in Crispr Therapeutics Ag, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.